DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced plans to offer 5,000,000 shares of its common stock in an underwritten public offering from its existing shelf registration statement. The underwriters will be granted an option to purchase up to an additional 750,000 shares of Abiomed’s common stock to cover over-allotments.
